NF1 and neurofibromatosis type 1: Since neurofibromin works as a tumor suppressor protein, impaired neurofibromin leads to upregulated Ras activity and increased cell growth, which is consistent with the tumor predisposition syndrome and aggregation cells in vessels observed in NF1 patients (Sasaki et al., 1995; Ly and Blakeley, 2019).